| Old Articles: <Older 25751-25760 Newer> |
|---|
 |
The Motley Fool
August 28, 2007
Anders Bylund |
Foolish Forecast: No Umbrage at Ciena The wide-area networking specialist is set to report its third-quarter earnings shortly. Investors, here is what you can expect to see.   |
The Motley Fool
August 28, 2007
Selena Maranjian |
The Green Giants of Wall Street Which companies are doing their part to help the environment? Investors, a few risks early on for eco-friendly firms may pay off later. |
The Motley Fool
August 27, 2007
Jeremy MacNealy |
Fool on Call: Abercrombie's Growth Spurt With RUEHL improving, a new concept under way, and aggressive international expansion imminent, investors can see at least three solid reasons to consider Abercrombie as a possible long-term investment. |
The Motley Fool
August 27, 2007
Rich Smith |
Foolish Forecast: Citi Trends' Bustling Quarter The urban apparel retailer is set to report its fiscal second-quarter 2007 earnings shortly. Investors, here is what you can expect to see. |
The Motley Fool
August 27, 2007
Rick Aristotle Munarriz |
3 Stocks That Blew the Market Away Beat the market and the world will beat a path to your door. GameStop... Intuit... BJ's... |
The Motley Fool
August 27, 2007
S.J. Caplan |
Scouting the Latest IPOs An investor's roundup of new-issue hits, misses, and no-shows: Abraxas Energy Partners... McLeod USA... ZARS Pharma... Adnexus Therapeutics... Orion Energy Systems... |
The Motley Fool
August 27, 2007
Rich Smith |
Foolish Forecast: Net 1 UEPS The South African smart-card purveyor is set to report its fourth-quarter and fiscal 2007 earnings. Investors, here is what you can expect to see. |
The Motley Fool
August 27, 2007
Toby Shute |
A Chinese Flameout Not every Chinese stock is flying today. Investors, China Sunergy released its second-quarter earnings results. |
The Motley Fool
August 27, 2007
Lawrence Rothman |
H.J. Heinz's Appetizing Results The condiment maker offers tasty earnings numbers to investors. |
The Motley Fool
August 27, 2007
Brian Orelli |
Repairing a Broken Heart Stem cells may be the new cure. If research continues on track, Geron expects to ask FDA to start clinical trials late next year or in early 2009. Investors, take note. |
| <Older 25751-25760 Newer> Return to current articles. |
